1. INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors Author Hilton, John F., Ott, Patrick A., Hansen, Aaron R., Li, Zujun, Mathew, Matthen, Messina, Cristina H., Dave, Vimal, Ji, Xiao, Karpinich, Natalie O., Hirschfeld, Steven, Ballas, Marc, and Zandberg, Dan P. Published 2024 Full Text View/download PDF